Orasis Pharmaceuticals
Sharon Amzel-Sasson is a development and operations executive with 15 years of experience leading drug development (CMC) and project management teams in the biomedical industry, both in large multinational corporations as well as in startup environments. Ms. Amzel-Sasson is an expert in the development and manufacturing of pharmaceutical drugs and drug-device combination products, with extensive expertise in ophthalmic and sterile products.
Ms. Amzel-Sasson holds an MBA from Tel Aviv University and a B.S. in biotechnology and food engineering from the Technion – Israel Institute of Technology.
This person is not in any offices
Orasis Pharmaceuticals
2 followers
Orasis is an emerging ophthalmic pharmaceutical company with the goal of making near vision clear again. They are committed to the Ophthalmology and Optometry segments because they know that presbyopia is ubiquitous. By virtue of their first in class formulation, Orasis is well-positioned to be first-line therapy in this emerging category by addressing a significant unmet need for patients.